0001209191-17-030238.txt : 20170505
0001209191-17-030238.hdr.sgml : 20170505
20170505132642
ACCESSION NUMBER: 0001209191-17-030238
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170503
FILED AS OF DATE: 20170505
DATE AS OF CHANGE: 20170505
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC
CENTRAL INDEX KEY: 0000914475
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330525145
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 617-7600
MAIL ADDRESS:
STREET 1: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nevinny Corinne H
CENTRAL INDEX KEY: 0001182467
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22705
FILM NUMBER: 17817445
MAIL ADDRESS:
STREET 1: C/O EDWARDS LIFESCIENCES CORPORATION
STREET 2: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
FORMER NAME:
FORMER CONFORMED NAME: LYLE CORINNE H
DATE OF NAME CHANGE: 20020823
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-05-03
0
0000914475
NEUROCRINE BIOSCIENCES INC
NBIX
0001182467
Nevinny Corinne H
12780 EL CAMINO REAL
SAN DIEGO
CA
92130
1
0
0
0
Common Stock
2017-05-03
4
M
0
15000
3.40
A
40555
D
Common Stock
2017-05-03
4
F
0
952
53.37
D
39603
D
Non-Qualified Stock Option
3.40
2017-05-03
4
M
0
15000
0.00
D
2010-06-25
2017-05-25
Common Stock
15000
0
D
The share issuance reported on Table I reflects shares issued upon the exercise of options granted on May 25, 2010, which, if unexercised would have expired on May 25, 2017. The option exercises are reported on Table II. These option exercises were pursuant to a net issuance arrangement effected under the issuer's Equity Incentive Plan. The number of shares issued pursuant to the net issuance arrangement was calculated as follows: the option exercise price ($3.40) was subtracted from the May 03, 2017 market close price ($53.57), and this net amount ($50.17) was then multiplied by the number of options (15,000), with the resulting amount then divided by the market close price to result in a net issuance of 14,048 shares to the optionee. The 952 shares underlying the remaining portion of the options are not available for re-issuance, and no shares were sold into the market as a part of the exercise in connection with a net issuance program.
/s/ Darin Lippoldt, Attorney-In-Fact
2017-05-05